1. Home
  2. CLPT vs MRVI Comparison

CLPT vs MRVI Comparison

Compare CLPT & MRVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ClearPoint Neuro Inc.

CLPT

ClearPoint Neuro Inc.

HOLD

Current Price

$9.27

Market Cap

494.6M

Sector

Health Care

ML Signal

HOLD

Logo Maravai LifeSciences Holdings Inc.

MRVI

Maravai LifeSciences Holdings Inc.

HOLD

Current Price

$3.67

Market Cap

472.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CLPT
MRVI
Founded
1998
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
494.6M
472.8M
IPO Year
2009
2020

Fundamental Metrics

Financial Performance
Metric
CLPT
MRVI
Price
$9.27
$3.67
Analyst Decision
Strong Buy
Buy
Analyst Count
2
7
Target Price
$26.50
$4.57
AVG Volume (30 Days)
813.7K
1.1M
Earning Date
04-06-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
22.22
14.29
EPS
N/A
N/A
Revenue
$31,390,000.00
$185,743,000.00
Revenue This Year
$18.93
$11.80
Revenue Next Year
$51.64
$7.74
P/E Ratio
N/A
N/A
Revenue Growth
31.04
N/A
52 Week Low
$8.63
$1.67
52 Week High
$30.10
$4.11

Technical Indicators

Market Signals
Indicator
CLPT
MRVI
Relative Strength Index (RSI) 29.55 62.09
Support Level N/A $3.65
Resistance Level $11.69 $4.03
Average True Range (ATR) 0.97 0.18
MACD -0.59 0.09
Stochastic Oscillator 8.15 78.64

Price Performance

Historical Comparison
CLPT
MRVI

About CLPT ClearPoint Neuro Inc.

ClearPoint Neuro Inc is a medical device company based in the United States. It develops and commercializes platforms for performing minimally invasive surgical procedures in the brain and heart under direct, intra-procedural magnetic resonance imaging (MRI) guidance. The company's ClearPoint system, which is in commercial use, is used to perform minimally invasive surgical procedures in the brain. The company's products include the ClearPoint system, ClearPoint Services, ClearPoint Disposables, ClearPoint Software, and ClearPoint Therapeutic Solutions.

About MRVI Maravai LifeSciences Holdings Inc.

Maravai LifeSciences Holdings Inc is a life sciences company that provides critical products that drive the development of groundbreaking vaccines, drug therapies, cell and gene therapies, and diagnostics. The group's solutions empower research into human diseases and support the entire biopharmaceutical development process from early discovery to commercialization. Its reportable segments are Nucleic acid production and biologics safety testing. It generates a majority of its revenue from Nucleic Acid Production and focuses on the manufacturing and sale of nucleic acid products to support the needs of customers' research, and therapeutic and vaccine programs. In addition, the segment also provides research products for labeling and detecting proteins in cells and tissue samples.

Share on Social Networks: